Supplement

See all supplements

Tuberculosis

Vol. 502 No. 7470_supp ppS1-S43
  • In this Supplement

  • Drug resistance and the HIV pandemic have thwarted efforts to rid the world of humanity's biggest killer Mycobacterium tuberculosis. We need new types of safe drug, a practical point-of-care diagnostic and ultimately an effective vaccine if we are ever to eliminate tuberculosis. But first we need a better understanding of the underlying biology.

    Cover Art: Neil Webb

Outlook

Top

Collection

Top
  • The Mycobacterium tuberculosis regulatory network and hypoxia

    • James E. Galagan
    • Kyle Minch
    • Matthew Peterson
    • Anna Lyubetskaya
    • Elham Azizi
    • Linsday Sweet
    • Antonio Gomes
    • Tige Rustad
    • Gregory Dolganov
    • Irina Glotova
    • Thomas Abeel
    • Chris Mahwinney
    • Adam D. Kennedy
    • René Allard
    • William Brabant
    • Andrew Krueger
    • Suma Jaini
    • Brent Honda
    • Wen-Han Yu
    • Mark J. Hickey
    • Jeremy Zucker
    • Christopher Garay
    • Brian Weiner
    • Peter Sisk
    • Christian Stolte
    • Jessica K. Winkler
    • Yves Van de Peer
    • Paul Iazzetti
    • Diogo Camacho
    • Jonathan Dreyfuss
    • Yang Liu
    • Anca Dorhoi
    • Hans-Joachim Mollenkopf
    • Paul Drogaris
    • Julie Lamontagne
    • Yiyong Zhou
    • Julie Piquenot
    • Sang Tae Park
    • Sahadevan Raman
    • Stefan H. E. Kaufmann
    • Robert P. Mohney
    • Daniel Chelsky
    • D. Branch Moody
    • David R. Sherman
    • Gary K. Schoolnik

    Nature499, 178–183 ()

Sponsor:

Janssen Research and Development LLC